Skip to content

Lowering Drug Costs for American Families Act

In committee: it can still change before the session ends.

US HR 6166 · House Bill · 119th Congress

Draft a letter
Stage
In committee
Started in
House
Sponsors
59
Latest action
Nov 20, 2025

What it does

The bill would expand the Medicare drug price negotiation program to include more drugs and extend its negotiated prices to private health insurance plans, requiring insurers to apply maximum fair prices to cost-sharing for covered drugs. It would also repeal certain changes made by Public Law 119–21, apply Medicare prescription drug inflation rebates to the commercial market, and establish out-of-pocket limits on prescription drug expenditures under private health insurance. These provisions affect group health plans, health insurance issuers, and individuals enrolled in such plans, including participants, beneficiaries, and enrollees in both group and individual markets. The bill mandates…

No official summary is available here. This one was written by AI from the bill’s text.

Read the full textRead it on the official site

Where it stands

  1. Introduced (Done)

    Nov 20, 2025

  2. Committee (Current step)

    In committee · Nov 20, 2025

  3. Floor (Not started)

  4. Law (Not started)

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

Where it goes next

While a bill can still move, the questions are about people and money.

Work with this bill

Lowering Drug Costs for American Families Act | 52